De-escalation of Radiotherapy for HPV-Associated Oropharyngeal Cancer De-escalation of Radiotherapy for HPV-Associated Oropharyngeal Cancer
For patients with HPV-positive oropharyngeal cancer undergoing definitive concurrent chemoradiotherapy, reduced radiation dose and volume to elective treatment regions yields ' uncompromised ' disease control with favorable toxicity, a study suggests.Reuters Health Information
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Hematology | Oropharyngeal Cancer | Radiology | Study | Toxicology